Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic enzymes and bile acids in severely ill children with severe malnutrition
PACTR202102678743565Phase 3Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Mar 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3 trial of pancreatin in severe acute malnutrition (SAM) (4 arms), sponsored by University of Oxford. Primary endpoint: Death. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
pancreatin
03
Conditions
severe acute malnutrition (SAM)
Beyond the preview
Go deeper on PACTR202102678743565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102678743565.